Safety of treatment for gastroparesis. - Wikidata - wikimedia - TriplyDB

Safety of treatment for gastroparesis.

Safety of treatment for gastroparesis.

http://www.wikidata.org/entity/Q38794290

about

From Harmful Treatment to Secondary Gain: Adverse Event Reporting in Dyspepsia and Gastroparesis.

P2860

Q38747262-689FAEC2-8A70-45FE-B4AD-253DB92E6A1E

P2860

Safety of treatment for gastroparesis.

http://www.wikidata.org/entity/Q38794290

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Safety of treatment for gastroparesis.

@en

type

label

Safety of treatment for gastroparesis.

@en

prefLabel

Safety of treatment for gastroparesis.

@en

P1433

Q38794290-4A0DDD52-63C3-428B-87C5-83BDE73C5241

P1476

Q38794290-0C0FFB60-1FEC-4FE1-A3F4-5768DA82BC95

P2093

Q38794290-5E8793D6-CB92-4553-900E-AC49B22C4C8A

Q38794290-8E246E50-B7C4-4E3B-90D6-A54282A95A32

Q38794290-D9E4A3CC-A2D3-48EE-93AC-A9FDA1EA9676

P2860

Q38794290-0B7ED3AD-2B39-472D-8B93-03FD62C77852

Q38794290-195840D9-FD88-47D4-8712-3E634BBA5B13

Q38794290-268D33E3-7B39-4B44-9748-0927D169B09B

Q38794290-2765D603-CC20-4367-9112-882B453EEADA

Q38794290-2EE07A45-BDA5-4F1A-81D2-98B021DD09CE

Q38794290-34FB34A4-59CA-40F0-B1A0-C1914943FF44

Q38794290-3670D3F6-BA01-4599-8BD4-FAF97266265B

Q38794290-3FAFE8D2-2DFE-4B3A-AB41-999A015CACBC

Q38794290-42B85338-133F-43FC-91C5-97726AB6F1D4

Q38794290-47EB89DE-0879-434D-B3F5-95CD29F8C76D

P304

Q38794290-A987FD38-E095-4FFB-83C9-5ACFFA0E0143

P31

Q38794290-CC9F40E4-2C13-4842-9A53-96AE7C37F0BD

P356

Q38794290-1A722D76-5484-49C1-9854-2D4FA8E631E2

P407

Q38794290-0778AC6C-0C18-4D67-A3EB-FC95F2D39AFB

P433

Q38794290-EC857A2E-EE9A-455C-A513-9DC5E6BB4A27

P478

Q38794290-CE1527EB-8B55-44AA-9AA1-C908FCFCE9B6

P577

Q38794290-DF91E2BB-9567-436A-8FCC-0A5E597ADA3B

P698

Q38794290-E1711425-31CE-4661-934A-6EEE29CDECEE

P356

14740338.2016.1173204

P1433

Expert Opinion on Drug Safety

P1476

Safety of treatment for gastroparesis.

@en

P2093

Irene Sarosiek

http://www.w3.org/2001/XMLSchema#string

Mohammad Bashashati

http://www.w3.org/2001/XMLSchema#string

Richard W McCallum

http://www.w3.org/2001/XMLSchema#string

P2860

Tricyclic antidepressant pharmacology and therapeutic drug interactions updated

SSRI Antidepressant Medications: Adverse Effects and Tolerability

Neuroleptic malignant syndrome induced by domperidone

A systematic review on intrapyloric botulinum toxin injection for gastroparesis.

Prokinetic activity of nizatidine: implications for the management of patients with gastroesophageal reflux disease.

Effect of nortriptyline on symptoms of idiopathic gastroparesis: the NORIG randomized clinical trial

Clinical guideline: management of gastroparesis

Risk of serious ventricular arrhythmia and sudden cardiac death in a cohort of users of domperidone: a nested case-control study.

Domperidone and ventricular arrhythmia or sudden cardiac death: a population-based case-control study in the Netherlands.

Clinical trial: the efficacy and tolerability of velusetrag, a selective 5-HT4 agonist with high intrinsic activity, in chronic idiopathic constipation - a 4-week, randomized, double-blind, placebo-controlled, dose-response study.

P304

937-945

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/14740338.2016.1173204

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P577

2016-03-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27031006

http://www.w3.org/2001/XMLSchema#string